Related Experiment Video
Updated: Sep 18, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
A Systematic Review of Cardiovascular Health Among Cancer Survivors
Miriam A Miles1, Oluseun Akinyele1, Abigail A Ninson2
1Department of Medicine, Division of General Internal Medicine and Population Science, University of Alabama at Birmingham, Boshell Diabetes Building, Birmingham, AL 35233, USA.
Insights
Cancer survivors often have poor cardiovascular health (CVH), increasing mortality risk. Improving CVH through lifestyle changes and education is crucial for this population.
Area of Science:
- Cardiovascular disease (CVD) research
- Cancer survivorship studies
- Public health and preventative medicine
Background:
- Cardiovascular disease (CVD) is a leading cause of death in cancer survivors, with lifestyle factors impacting both cancer and cardiovascular mortality.
- Cardiovascular health (CVH), defined by metrics like Life's Simple 7 (LS7) or Life's Essential 8 (LE8), is understudied in cancer survivors despite its association with cancer mortality.
- Less than ideal CVH is linked to increased cancer mortality, highlighting a critical need for research in this area.
Approach:
- A systematic review was conducted following PRISMA guidelines, searching major databases (PubMed, Scopus, CINAHL, Embase) for studies on cancer survivors and cardiovascular health.
- Keywords included "cancer survivors", "cancer patient", "cardiovascular health", and "cardiovascular risk factors", with articles assessed for risk of bias and synthesized.
- Ten studies met inclusion criteria, utilizing LS7 or LE8 metrics to assess CVH in a population of 35,980 cancer survivors (ages 40-70).
Key Points:
- The review identified four emergent themes: CVH outcomes in cancer survivors, social determinants influencing CVH, associations between CVH and other health outcomes, and opportunities for CVH awareness.
- The majority of included studies focused on survivors of breast, gynecological, endometrial, prostate, colon, lung, lymphoma, and skin cancers.
- The analyzed population (n=35,980) comprised mostly female, non-Black individuals with an average survivorship of 7.2 years.
Conclusions:
- Cancer survivors frequently exhibit less than ideal cardiovascular health outcomes.
- Interventions focused on education and empowerment are recommended to support lifestyle modifications that can improve CVH in cancer survivors.
- Addressing CVH in cancer survivorship is essential for reducing overall mortality and improving long-term health trajectories.
Abstract:
Cardiovascular disease (CVD) is the most common non-cancer cause of death among cancer survivors. Lifestyle and clinical factors associated with cancer mortality are also associated with cardiovascular mortality. The American Heart Association (AHA) has termed these factors "cardiovascular health" (CVH), using Life's Simple 7 (LS7) or "Life's Essential 8 (LE8)" to determine poor, intermediate, and high (ideal) CVH. Further, less than ideal CVH is associated with higher cancer mortality. Yet, CVH among cancer survivors remains understudied. This systematic review examined the extant literature, providing a comprehensive report of the findings addressing CVH among cancer survivors.
Methods:
Using PRISMA guidelines, we systematically examined CVH among cancer survivors (including patients) within PubMed, Scopus, CINAHL, and Embase databases without date limitations from June 2024 to December 2024 using the following keywords: "cancer survivors", "cancer patient", "cardiovascular health", and "cardiovascular risk factors". Two reviewers independently accessed articles in concordance with LS7 and LE8 metrics. The included studies were examined and assessed for risk of bias and synthesized to elucidate themes of CVH among cancer survivors.
Results:
We retrieved 2935 studies examining breast, gynecological, endometrial, prostate, colon, lung, lymphoma, and skin cancer survivors published from 2002-2024. Overall, 10 studies met criteria utilizing LS7 or LE8 CVH health outcomes (4 LS7, 5 LE8, and 1 LS7/LE8), ages 40-70 years, with a population (n = 35,980) consisting of mostly female, non-Black individuals; mean survivorship was 7.2 years. Four themes emerged: CVH outcomes among cancer survivors, social factors impacting CVH outcomes, associations of CVH, and other health outcomes opportunities for CVH awareness.
Conclusions:
We found that cancer survivors frequently report less than ideal CVH outcomes and would benefit from education/empowerment to support lifestyle changes that improve CVH.
More Related Videos
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cancer Survival Analysis
Cancer Prevention
Some...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease IV: Preventive Measures
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

